Projects per year
Personal profile
Biography
Jennifer Whitty is an applied health economist with a professional background in pharmacy. She has considerable research leadership and consultancy experience in:
|
Jennifer’s research has a person-centred and multidisciplinary focus. She leads a program of research with a particular focus on evaluating patient and public preferences, choices and values around health outcomes and services. Her research contributes to the development of methods for measuring preferences and valuing quality of life and other outcomes from healthcare, and she is an expert in the application of choice-based stated preference approaches such as the discrete choice experiment. Jennifer is the leading health economics investigator for research projects funded by the Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC), including the NHMRC Centre of Research Excellence in Telehealth. She has been awarded funding exceeding AU$9 million as a Chief Investigator or Fellow, approximately AU$10 million as Associate Investigator, and exceeding AU$8 million as a consultant on research grants. She has over 70 peer-reviewed journal publications and is a member of the Editorial Board for the international journals “Medical Decision Making” and “Applied Health Economics and Health Policy”. Jennifer has contributed to health policy development as a member of the National Immunoglobulin Governance Advisory Committee, which is a national advisory body in Australia supporting the effective and efficient governance of immunoglobulin products funded under the national blood arrangements.
Prior to her academic career, Jennifer has diverse experience working in the health system as a pharmacist, in both the United Kingdom and Australia. She has completed a Graduate Diploma in Clinical Pharmacy, and has promoted the quality use of medicines in clinical and policy settings. Jennifer’s research has retained a focus on the evaluation of health services, models of care, and health technologies including pharmaceuticals. She has worked closely with Government Health Departments and is an experienced evaluator of submissions made by pharmaceutical companies to have their products listed on the Australian Pharmaceutical Benefits Scheme (PBS).
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, Griffith University Queensland
Award Date: 21 Nov 2008
University of Queensland
Award Date: 1 Dec 2002
Bachelor of Pharmacy, University of Wales
Award Date: 1 Jul 1992
Collaborations and top research areas from the last five years
-
A randomised open label trial to assess change in respiratory function for people with cystic fibrosis(pwCF) established on triple combination therapy (Kaftrio™) after rationalisation of nebulised mucoactive therapies (the CF STORM trial)
National Institute for Health and Care Research
1/02/21 → 31/01/24
Project: Research
-
Health Economics and Prioritisation in Health & Social Care Them (ARC)
Wagner, A., Lartey, S., Whitty, J. & Cameron, R.
National Institute for Health and Care Research
1/10/19 → 30/09/24
Project: Research
-
Scoping study - Value-based care in mental health CPFT Project
Wagner, A., Whitty, J., Whitty, J. & Cameron, R.
1/08/21 → 31/07/23
Project: Research
-
A discrete choice experiment to derive health utilities for aromatic L-amino acid decarboxylase (AADC) deficiency in France
Smith, A. B., Hanbury, A., Whitty, J. A., Beitia Ortiz de Zarate, I., Hammes, F., de Pouvourville, G. & Buesch, K., 25 Jan 2022, In: Patient Related Outcome Measures. 13, p. 21-30 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Downloads (Pure) -
Consumer preference and willingness-to-pay for direct-to-consumer mobile-teledermoscopy services in Australia
Snoswell, C. L., Whitty, J. A., Caffery, L. J., Kho, J., Horsham, C., Loescher, L. J., Vagenas, D., Gillespie, N., Soyer, H. P. & Janda, M., 1 Mar 2022, In: Dermatology. 238, 2, p. 358-367 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)8 Downloads (Pure) -
Development of a preference-based heart disease-specific health state classification system using MacNew heart disease related quality of life instrument
Kularatna, S., Rowen, D., Mukuria, C., McPhail, S., Chen, G., Mulhern, B., Whitty, J. A., Byrnes, J. M., Scuffham, P. A., Atherton, J., Höfer, S. & Parsonage, W., Jan 2022, In: Quality of Life Research. 31, p. 257–268 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Exploring the nature of perceived treatment burden: a study to compare treatment burden measures in adults with cystic fibrosis.
Altabee, R., Carr, S. B., Abbott, J., Cameron, R., Office, D., Matthews, J., Simmonds, N., Cosgriff, R., Turner, D. & Whitty, J., 9 May 2022, In: NIHR Open Research. 2, 36.Research output: Contribution to journal › Article › peer-review
Open Access -
How do people with experience of infertility value different aspects of assistive reproductive therapy? Results from a multi-country discrete choice experiment
Skedgel, C., Ralphs, E., Finn, E., Markert, M., Samuelsen, C. & Whitty, J. A., Jul 2022, In: The Patient - Patient-Centered Outcomes Research. 15, 4, p. 459–472 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Citations (Scopus)5 Downloads (Pure)